S-8 – Page 32 – China Stock Advice

SVA [SINOVAC BIOTECH] S-8: (Original Filing)

[2012 Share Incentive Plan (Full title of the plan) Law Debenture Corporate Services Inc. 400 Madison Avenue, 4th Floor 7 New York, New York 1001 (Name and address of agent for service) (212) 750-6474 (Telephone number, including area code, of agent for service) Copies to: Eugene Y. Lee Latham & Watkins 18th Floor, One Exchange Square 8 Connaught Place, Central] [[Letterhead of RICHARDS & COMPANY] September 4, 2013 Sinovac Biotech Ltd. No. 39 Shanghai Xi Road Haidan District, Beijing, 100085 People’s Republic of China Re: Sinovac Biotech Ltd (‘the Company”) As Antigua and Barbuda legal counsel to the Company, we have examined (i) the Registration Statement, (ii) the Plan, (iii) the articles of incorporation and by-laws of the Company and] [Consent of Independent Registered Public Accounting Firm Vancouver, Canada September 4, 2013 Chartered Accountants] [SINOVAC BIOTECH LTD. ARTICLE 1. Plan Company The purpose of the Sinovac Biotech Ltd. 2012 Share Incentive Plan (the “ ARTICLE 2. Wherever the following terms are used in the Plan they shall have the meanings specified below, unless the context clearly indicates otherwise. The singular pronoun shall include the plural where the context so indicates. Administrator 2.1 “ Applicable]

By info| 2016-03-24T00:14:25+00:00 September 4th, 2013|Categories: Chinese Stocks, SEC Original, SVA|Tags: 0001084201, 2013-09-04, 2834, PHARMACEUTICAL PREPARATIONS, S-8, SVA|0 Comments

SVA [SINOVAC BIOTECH] S-8: 2012 Share Incentive Plan (Full title of the

[2012 Share Incentive Plan (Full title of the plan) Law Debenture Corporate Services Inc. 400 Madison Avenue, 4th Floor 7 New York, New York 1001 (Name and address of agent for service) (212) 750-6474 (Telephone number, including area code, of agent for service) Copies to: Eugene Y. Lee Latham & Watkins 18th Floor, One Exchange Square 8 Connaught Place, Central] [[Letterhead of RICHARDS & COMPANY] September 4, 2013 Sinovac Biotech Ltd. No. 39 Shanghai Xi Road Haidan District, Beijing, 100085 People’s Republic of China Re: Sinovac Biotech Ltd (‘the Company”) As Antigua and Barbuda legal counsel to the Company, we have examined (i) the Registration Statement, (ii) the Plan, (iii) the articles of incorporation and by-laws of the Company and] [Consent of Independent Registered Public Accounting Firm Vancouver, Canada September 4, 2013 Chartered Accountants] [SINOVAC BIOTECH LTD. ARTICLE 1. Plan Company The purpose of the Sinovac Biotech Ltd. 2012 Share Incentive Plan (the “ ARTICLE 2. Wherever the following terms are used in the Plan they shall have the meanings specified below, unless the context clearly indicates otherwise. The singular pronoun shall include the plural where the context so indicates. Administrator 2.1 “ Applicable]

By info| 2016-03-24T00:15:21+00:00 September 4th, 2013|Categories: Chinese Stocks, SVA, Webplus ver|Tags: 0001084201, 2013-09-04, 2834, PHARMACEUTICAL PREPARATIONS, S-8, SVA|0 Comments

BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)

[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]

By info| 2016-03-03T10:52:24+00:00 August 28th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2013-08-28, 2834, BSPM, PHARMACEUTICAL PREPARATIONS, S-8|0 Comments

BSPM [Biostar Pharmaceuticals,] S-8: FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT

[FORM S-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 including zip code) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer No. 588 Shiji Xi Avenue,] [Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan This Biostar Pharmaceuticals, Inc. 2012 Stock Option Compensation Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, Inc. No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China Ladies and Gentlemen: Schiff Hardin LLP EX-5.1 3 ex5-1.htm] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 dated August 28, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong August 28, 2013 EX-23.2 5 ex23-2.htm]

By info| 2016-03-03T10:54:47+00:00 August 28th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2013-08-28, 2834, BSPM, PHARMACEUTICAL PREPARATIONS, S-8|0 Comments

BSPM [Biostar Pharmaceuticals,] S-8: (Original Filing)

[FORMS-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China 712046luding zipde) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer] [Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan This Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan Plan 1. Definitions. (a) Board " (b)de " (c)mmittee Rule 16b-3 Exchange Act " (d)mpany " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grantreement] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China Ladies and Gentlemen:hiff Hardin ex5-1.htm 3 EX-5.1] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to theorporation by reference in the Registration Statement on Form S-8ted August 28, 2013 of Biostar Pharmaceuticals, of our reportted April 11, 2013 relating to thensolidated financial statements, which appears in the Annual Report on Form 10-K of Biostar] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong August 28, 2013 ex23-2.htm 5 EX-23.2]

By info| 2016-02-07T15:12:38+00:00 August 28th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2013-08-28, 2834, BSPM, PHARMACEUTICAL PREPARATIONS, S-8|0 Comments

BSPM [Biostar Pharmaceuticals,] S-8: FORMS-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER

[FORMS-8 SECURITIES ACT OF 1933 REGISTRATION STATEMENT UNDER THE Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 20-5101287 (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China 712046luding zipde) (Full title of the plan) Ronghua Wang, President and Chief Executive Officer] [Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan This Biostar Pharmaceuticals, 2012 Stock Optionmpensation Plan Plan 1. Definitions. (a) Board " (b)de " (c)mmittee Rule 16b-3 Exchange Act " (d)mpany " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grantreement] [[Schiff Hardin letterhead] August 28, 2013 Biostar Pharmaceuticals, No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China Ladies and Gentlemen:hiff Hardin ex5-1.htm 3 EX-5.1] [Consent of Independent Registered Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, We herebynsent to theorporation by reference in the Registration Statement on Form S-8ted August 28, 2013 of Biostar Pharmaceuticals, of our reportted April 11, 2013 relating to thensolidated financial statements, which appears in the Annual Report on Form 10-K of Biostar] [Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong August 28, 2013 ex23-2.htm 5 EX-23.2]

By info| 2016-02-07T15:13:34+00:00 August 28th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2013-08-28, 2834, BSPM, PHARMACEUTICAL PREPARATIONS, S-8|0 Comments

EJ [E-HOUSE (CHINA)] S-8: (Original Filing)

[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 E-House (China) Holdings Limited Cayman Islands Not Applicable (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 17/F, East Tower No. 333 North Chengdu Road Shanghai, PRC 200041 Peoples Republic of China E-House (China) Holdings Limited Share Incentive Plan (amended and restated on October 16, 2008) (Full] [Our Ref SSY/618586-000001/6328324v2 Direct tel +852 2971 3046 Email richard.spoooner@maplesandcalder.com E-House (China) Holdings Limited 17/F, East Tower No. 333 North Chengdu Road Shanghai 200041 Peoples Republic of China 26 August 2013 Dear Sirs E-House (China) Holdings Limited Company Registration Statement We have examined the Registration Statement on Form S-8 to be filed by E-House (China) Holdings Limited, a Cayman Islands] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports relating to the financial statements of E-House (China) Holdings Limited and the effectiveness of E-House (China) Holdings Limited internal control over financial reporting dated April 17, 2013, appearing in the Annual Report on Form 20-F of]

By info| 2016-03-31T04:11:12+00:00 August 26th, 2013|Categories: Chinese Stocks, EJ, SEC Original|Tags: 0001405658, 2013-08-26, 6531, EJ, REAL ESTATE AGENTS and MANAGERS (FOR OTHERS), S-8|0 Comments

EJ [E-HOUSE (CHINA)] S-8: FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 E-House (China) Holdings Limited Cayman Islands Not Applicable (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification Number) 17/F, East Tower No. 333 North Chengdu Road Shanghai, PRC 200041 Peoples Republic of China E-House (China) Holdings Limited Share Incentive Plan (amended and restated on October 16, 2008) (Full] [Our Ref SSY/618586-000001/6328324v2 Direct tel +852 2971 3046 Email richard.spoooner@maplesandcalder.com E-House (China) Holdings Limited 17/F, East Tower No. 333 North Chengdu Road Shanghai 200041 Peoples Republic of China 26 August 2013 Dear Sirs E-House (China) Holdings Limited Company Registration Statement We have examined the Registration Statement on Form S-8 to be filed by E-House (China) Holdings Limited, a Cayman Islands] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports relating to the financial statements of E-House (China) Holdings Limited and the effectiveness of E-House (China) Holdings Limited internal control over financial reporting dated April 17, 2013, appearing in the Annual Report on Form 20-F of]

By info| 2016-03-31T04:13:42+00:00 August 26th, 2013|Categories: Chinese Stocks, EJ, Webplus ver|Tags: 0001405658, 2013-08-26, 6531, EJ, REAL ESTATE AGENTS and MANAGERS (FOR OTHERS), S-8|0 Comments

QIHU [Qihoo 360 Technology Co] S-8: Cayman Islands Not Applicable (State or other jurisdiction

[Cayman Islands Not Applicable (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Building No. 2 6 Jiuxianqiao Road, Chaoyang District Beijing 100015, People’s Republic of China Telephone number: +86-10-5878-1000 Qihoo 360 Technology Co. Ltd. 2011 Share Incentive Plan (Full title of the plans) Corporation Service Company 1180 Avenue of the Americas, Suite 210 New York, New] [MAPLES Our Ref JJH/616655/6280341v1 Direct tell +852 3690 7444 Email jack.huang@maplesandcalder.com Qihoo 360 Technology Co. Ltd . Building No.2 6 Jiuxianqiao Road, Chaoyang District Beijing 100015, People's Republic of China 5 August 2013 Dear Sirs Qihoo 360 Techology Co. Ltd. "Company" , We have examined the Registration Statement on Form S-8 to be filed by Qihoo 360 Technology Co. Ltd.,] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated April 19, 2013, relating to the consolidated financial statements and the related financial statement schedule of Qihoo 360 Technology Co. Ltd., its subsidiaries, its variable interest entities (“VIEs”), and VIEs’ subsidiaries (collectively, the “Group”) and]

By info| 2016-03-20T03:30:31+00:00 August 5th, 2013|Categories: Chinese Stocks, QIHU, Webplus ver|Tags: 0001508913, 2013-08-05, 7371, QIHU, S-8, SERVICES-COMPUTER PROGRAMMING SERVICES|0 Comments

LAS [Lentuo International] S-8: (Original Filing)

[] [LENTUO INTERNATIONAL INC. Purposes of the Plan 1. · to attract and retain the best available personnel for positions of substantial responsibility; · to provide additional incentive to Employees, Directors and Consultants; and · to promote the success of the Company’s business. The Plan permits the grant of Incentive Stock Options, Nonstatutory Stock Options, Restricted Shares, Share Appreciation Rights, Restricted] [MAPLES Lentuo International Inc. Building D, 2/F, 56 East 4th Ring South Road Chaoyang District, Beijing 100023 People’s Republic of China 12 July 2013 Dear Sirs Lentuo International Inc. “Company”), “Registration Statement”), “Shares”) “Plan”). We have examined the Registration Statement on Form S-8 to be filed by Lentuo International Inc., a Cayman Islands exempted company incorporated with limited liability (the] [ERNST & YOUNG Ernst & Young Hua Ming LLP +86 21 2228 8888 Shanghai Branch +86 21 2228 0000 50/F, Shanghai ‘NorId Financial Center 100 Century Avenue, Pudong New Area Shanghai, China 200120 Tel: +86 21 2228 8888 Fax: +86 21 2228 0000 www.ey.com Consent of Independent Registered Public Accounting Firm Shanghai, the People’s Republic of China July 16, 2013]

By info| 2016-03-29T16:42:08+00:00 July 16th, 2013|Categories: Chinese Stocks, LAS, SEC Original|Tags: 0001499673, 2013-07-16, 5500, LAS, RETAIL-AUTO DEALERS and GASOLINE STATIONS, S-8|0 Comments